Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential

Cardiovasc Res. 2001 Feb 1;49(2):351-60. doi: 10.1016/s0008-6363(00)00259-5.

Abstract

Objectives: To study the blocking effects of H 345/52 on ionic currents of rabbit ventricular myocytes and how these features translate into a proarrhythmic potential.

Methods: The single electrode voltage clamp technique was used to study the effects of H 345/52 on the rapid component of the delayed rectifying potassium current, I(Kr), and the L-type calcium current (I(Ca)). Differential effects of H 345/52 and almokalant on APD prolongation were studied in a rabbit Purkinje fibre/ventricular muscle preparation. The temporal variability of the action potential duration (APD) and its relation to proarrhythmias was examined in Langendorff-perfused rabbit hearts administered H 345/52 or almokalant. Anaesthetised, methoxamine-sensitised rabbits were used to assess the propensity of intravenous H 345/52 and ibutilide to induce torsades de pointes (TdP).

Results: H 345/52 potently blocked I(Kr) (IC(50)=40 nM) without consequential use-dependency. The I(Ca) was also blocked, but at higher concentrations (IC(50)=1.3 microM). Block of I(Ca) was markedly frequency-dependent (positive) and influenced by membrane potential, such that H 345/52 was more effective following clamp steps from plateau potentials than from -80 mV. In the Purkinje fibre-ventricular muscle preparation, almokalant prolonged the Purkinje fibre APD preferentially, whereas H 345/52 homogeneously prolonged APD in both tissue types. In the perfused rabbit heart, H 345/52 (1 microM) and almokalant (0.3 microM) prolonged APD to a similar degree but increased the temporal variability of APD differently, from 3+/-0.4 ms in control hearts to 8+/-1.2 ms and to 38+/-7.5 ms (P<0.001 vs. H 345/52), respectively. Unequivocal early after-depolarisations were seen in 5/6 almokalant-perfused hearts but in no heart administered H 345/52 (P<0.05). In anaesthetised rabbits, H 345/52 (17.4 micromol/kg) or ibutilide (2.6 micromol/kg maximum), maximally lengthened the QT interval from 133+/-4.5 to 177+/-8.0 ms and from 125+/-5.1 to 166+/-9.3 ms (P<0.001, n=8). However, whereas ibutilide induced TdP in all animals at 0.06+/-0.009 micromol/kg, H 345/52 did not induce TdP (P=0.0002) at up to 17.4 micromol/kg.

Conclusions: H 345/52 blocks I(Kr) with high potency and I(Ca) with somewhat lower potency and was found to delay ventricular repolarisation without substantially increasing temporal or spatial dispersion and without inducing early after-depolarisations or TdP.

Publication types

  • Comparative Study

MeSH terms

  • Action Potentials / drug effects
  • Alkanes / pharmacology*
  • Animals
  • Anti-Arrhythmia Agents / pharmacology*
  • Bridged Bicyclo Compounds / pharmacology*
  • Calcium Channels, L-Type / drug effects*
  • Heart Ventricles / drug effects
  • Heart Ventricles / metabolism
  • In Vitro Techniques
  • Inhibitory Concentration 50
  • Male
  • Models, Animal
  • Patch-Clamp Techniques
  • Perfusion
  • Potassium Channels / drug effects*
  • Propanolamines / pharmacology
  • Purkinje Fibers / drug effects
  • Purkinje Fibers / metabolism
  • Rabbits
  • Sulfonamides / pharmacology
  • Torsades de Pointes / chemically induced
  • Torsades de Pointes / metabolism*

Substances

  • 3,7-diazabicyclo(3.3.1)nonane-3-carboxylic acid, 7-((2S)3-(4-cyanophenoxy)-2-hydroxypropyl)-1,1-dimethylethyl ester
  • Alkanes
  • Anti-Arrhythmia Agents
  • Bridged Bicyclo Compounds
  • Calcium Channels, L-Type
  • Potassium Channels
  • Propanolamines
  • Sulfonamides
  • ibutilide
  • almokalant